Why is Kwality Pharma falling/rising?

As of 08-Sep, Kwality Pharmaceuticals Ltd is experiencing a price increase, with its current price at 950.35, reflecting a rise of 12.35 or 1.32%. The stock has shown positive momentum, gaining for the last two consecutive days with a total return of 2.16% during this period. Additionally, the stock has outperformed its sector by 1.45%. Despite a decline of 16.09% over the past month, the company has demonstrated strong financial health, evidenced by a low Debt to EBITDA ratio of 1.03 times and consistent positive results over the last six quarters. The stock is trading at a discount compared to its peers, and its attractive valuation is supported by a PEG ratio of 0.6, indicating potential for growth.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has underperformed the Sensex by 3.52% over the past week, while the Sensex has gained 0.53%. However, the long-term performance remains strong, with a 20.75% return over the past year, significantly outperforming the Sensex, which has seen a decline of 0.49% in the same timeframe. The rising investor participation, indicated by a 20.16% increase in delivery volume, suggests growing confidence in the stock, further contributing to its upward price movement.